FDA Explains When Unsafe Cosmetics Can Face Mandatory Recalls
Published Date: 10/23/2026
Notice
Summary
The FDA just released clear answers about how they’ll handle mandatory recalls of cosmetics if products are unsafe. This guidance helps companies understand when and how recalls happen, so they can act fast and keep customers safe. It’s official as of October 23, 2026, and companies should be ready to follow these rules to avoid costly problems.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Final FDA Guidance on Mandatory Cosmetics Recalls
On October 23, 2026 the FDA issued final guidance titled "Questions and Answers Regarding Mandatory Cosmetics Recalls." The guidance explains FDA's current thinking about the criteria, process, and expectations for mandatory recalls of cosmetic products to inform regulated companies how recall authority will be implemented.
No New Paperwork Requirements
The guidance states it contains no new collection of information, so clearance by the Office of Management and Budget under the Paperwork Reduction Act of 1995 is not required. This means the guidance does not introduce new OMB-cleared reporting or paperwork obligations for firms.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20848, Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods
The FDA is changing food rules to allow salt substitutes in many standardized foods, helping companies make lower-sodium options. This move aims to cut heart disease risks by reducing sodium without changing how foods basically taste or look. The new rule kicks in December 14, 2026, and food makers have until November 12, 2026, to raise any concerns, with no big costs expected.
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
Previous / Next Documents
Previous: 2026-21678, Free Application for Federal Student Aid (FAFSA®) Information To Be Verified for the 2027-2028 Award Year
If you’re applying for federal student aid for the 2027-2028 school year, some of your FAFSA info might need to be double-checked by your school. Most tax info will come straight from the IRS, so you won’t have to prove it again, but if you enter tax details yourself, be ready to show proof. This helps speed up the process and keeps everything fair and accurate for students and families.
Next: 2026-21681, Agency Information Collection Activities: Allegation of Counterfeiting and Intellectual Policy, ICE Form 73-048, OMB 1653-0053
ICE is updating a form that helps people report fake products and intellectual property crimes. This affects anyone who wants to report counterfeiting, including businesses and law enforcement. Comments on the update are open until December 22, 2026, with no new costs involved—just a smoother way to fight fakes and protect safety and the economy.